Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

SARS funding granted in HK, but insufficient in the US

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    SARS funding granted in HK, but insufficient in the US. Pharmacoecon. Outcomes News 414, 2 (2003). https://doi.org/10.1007/BF03276297

    Download citation

    Keywords

    • Outcome News
    • Severe Acute Respiratory Syndrome
    • Antiviral Agent
    • Public Health Issue
    • Public Health System